Puli Pharmaceuticals (300630.SZ) announced that the company received from the China Securities Regulatory Commission on May 8, 2024...
Zhitong Finance App News, Puli Pharmaceuticals (300630.SZ) announced that the company received the “Notice of Case Filing” from the China Securities Regulatory Commission on May 8, 2024. The China Securities Regulatory Commission decided to file a case against the company on May 8, 2024, according to relevant laws and regulations because the company did not disclose the 2023 annual report within the statutory period and is suspected of violating information disclosure regulations.